Clinical Trials Browser

Phase 3 × Colorectal Neoplasms × Ramucirumab × Clear all

NCT01183780 2019-09-25

A Study in Second Line Metastatic Colorectal Cancer

Phase 3 Completed

1,072 enrolled 17 charts

Gastrointestinal

Colorectal Neoplasms